Drug Type Monoclonal antibody |
Synonyms GSK 1070806 |
Target |
Mechanism IL-18 inhibitors(Interleukin 18 inhibitors) |
Active Indication |
Inactive Indication |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 2 | US | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | CN | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | JP | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | AR | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | BG | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | CA | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | CZ | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | FR | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | DE | 16 Nov 2023 | |
Dermatitis, Atopic | Phase 2 | GR | 16 Nov 2023 |
Phase 1 | - | - | enbsuitows(gpuhhpqkmb) = zcsjyxkeys zmvmvudaby (fmcdbywniz ) | Positive | 11 Oct 2023 | ||
Phase 2 | 7 | hcvxzyuwrv(xmspmlfcik) = hunddusfgv wwqhgbfokj (jmjvcajbkv ) View more | Negative | 08 Mar 2021 | |||
Phase 2 | 7 | bzslvlgcke(waqzxifxyw) = jagndlbswc hleazzmcxu (mmilmdgcoe, igdukrkecw - pkkmmpdvum) View more | - | 10 Jun 2019 |